graphic
graphic  
graphic
News > Deals
graphic
Immunex up on takeover talk
graphic December 13, 2001: 4:29 p.m. ET

Shares of biotech firm rise on rumors it is takeover target of Amgen.
graphic
graphic graphic
graphic
NEW YORK (CNN/Money) - Shares of biotechnology company Immunex Corp. jumped more than 12 percent Thursday on rumors that it is a takeover target of Amgen Inc., the world's largest biotech firm.

Amgen (AMGN: down $4.20 to $60.19, Research, Estimates) shares retreated more than 3 percent on the rumors, which would bring Immunex's rheumatoid arthritis drug Enbrel into its fold. Enbrel had sales of about $650 million in 2000.

Immunex (IMNX: up $2.51 to $26.96, Research, Estimates) had hoped to get approval for Enbrel to treat chronic heart failure, but was forced to withdraw the drug from trials in March after if proved to be ineffective.

Last month Amgen upped its guidance for earnings growth in 2002.

Both Amgen and Immunex declined to comment. graphic





graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.
graphic